Cargando…

Brown Adipose Tissue Energy Metabolism in Humans

The demonstration of metabolically active brown adipose tissue (BAT) in humans primarily using positron emission tomography coupled to computed tomography (PET/CT) with the glucose tracer 18-fluorodeoxyglucose ((18)FDG) has renewed the interest of the scientific and medical community in the possible...

Descripción completa

Detalles Bibliográficos
Autores principales: Carpentier, André C., Blondin, Denis P., Virtanen, Kirsi A., Richard, Denis, Haman, François, Turcotte, Éric E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090055/
https://www.ncbi.nlm.nih.gov/pubmed/30131768
http://dx.doi.org/10.3389/fendo.2018.00447
_version_ 1783347131939028992
author Carpentier, André C.
Blondin, Denis P.
Virtanen, Kirsi A.
Richard, Denis
Haman, François
Turcotte, Éric E.
author_facet Carpentier, André C.
Blondin, Denis P.
Virtanen, Kirsi A.
Richard, Denis
Haman, François
Turcotte, Éric E.
author_sort Carpentier, André C.
collection PubMed
description The demonstration of metabolically active brown adipose tissue (BAT) in humans primarily using positron emission tomography coupled to computed tomography (PET/CT) with the glucose tracer 18-fluorodeoxyglucose ((18)FDG) has renewed the interest of the scientific and medical community in the possible role of BAT as a target for the prevention and treatment of obesity and type 2 diabetes (T2D). Here, we offer a comprehensive review of BAT energy metabolism in humans. Considerable advances in methods to measure BAT energy metabolism, including nonesterified fatty acids (NEFA), chylomicron-triglycerides (TG), oxygen, Krebs cycle rate, and intracellular TG have led to very good quantification of energy substrate metabolism per volume of active BAT in vivo. These studies have also shown that intracellular TG are likely the primary energy source of BAT upon activation by cold. Current estimates of BAT's contribution to energy expenditure range at the lower end of what would be potentially clinically relevant if chronically sustained. Yet, (18)FDG PET/CT remains the gold-standard defining method to quantify total BAT volume of activity, used to calculate BAT's total energy expenditure. Unfortunately, BAT glucose metabolism better reflects BAT's insulin sensitivity and blood flow. It is now clear that most glucose taken up by BAT does not fuel mitochondrial oxidative metabolism and that BAT glucose uptake can therefore be disconnected from thermogenesis. Furthermore, BAT thermogenesis is efficiently recruited upon repeated cold exposure, doubling to tripling its total oxidative capacity, with reciprocal reduction of muscle thermogenesis. Recent data suggest that total BAT volume may be much larger than the typically observed 50–150 ml with (18)FDG PET/CT. Therefore, the current estimates of total BAT thermogenesis, largely relying on total BAT volume using (18)FDG PET/CT, may underestimate the true contribution of BAT to total energy expenditure. Quantification of the contribution of BAT to energy expenditure begs for the development of more integrated whole body in vivo methods.
format Online
Article
Text
id pubmed-6090055
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-60900552018-08-21 Brown Adipose Tissue Energy Metabolism in Humans Carpentier, André C. Blondin, Denis P. Virtanen, Kirsi A. Richard, Denis Haman, François Turcotte, Éric E. Front Endocrinol (Lausanne) Endocrinology The demonstration of metabolically active brown adipose tissue (BAT) in humans primarily using positron emission tomography coupled to computed tomography (PET/CT) with the glucose tracer 18-fluorodeoxyglucose ((18)FDG) has renewed the interest of the scientific and medical community in the possible role of BAT as a target for the prevention and treatment of obesity and type 2 diabetes (T2D). Here, we offer a comprehensive review of BAT energy metabolism in humans. Considerable advances in methods to measure BAT energy metabolism, including nonesterified fatty acids (NEFA), chylomicron-triglycerides (TG), oxygen, Krebs cycle rate, and intracellular TG have led to very good quantification of energy substrate metabolism per volume of active BAT in vivo. These studies have also shown that intracellular TG are likely the primary energy source of BAT upon activation by cold. Current estimates of BAT's contribution to energy expenditure range at the lower end of what would be potentially clinically relevant if chronically sustained. Yet, (18)FDG PET/CT remains the gold-standard defining method to quantify total BAT volume of activity, used to calculate BAT's total energy expenditure. Unfortunately, BAT glucose metabolism better reflects BAT's insulin sensitivity and blood flow. It is now clear that most glucose taken up by BAT does not fuel mitochondrial oxidative metabolism and that BAT glucose uptake can therefore be disconnected from thermogenesis. Furthermore, BAT thermogenesis is efficiently recruited upon repeated cold exposure, doubling to tripling its total oxidative capacity, with reciprocal reduction of muscle thermogenesis. Recent data suggest that total BAT volume may be much larger than the typically observed 50–150 ml with (18)FDG PET/CT. Therefore, the current estimates of total BAT thermogenesis, largely relying on total BAT volume using (18)FDG PET/CT, may underestimate the true contribution of BAT to total energy expenditure. Quantification of the contribution of BAT to energy expenditure begs for the development of more integrated whole body in vivo methods. Frontiers Media S.A. 2018-08-07 /pmc/articles/PMC6090055/ /pubmed/30131768 http://dx.doi.org/10.3389/fendo.2018.00447 Text en Copyright © 2018 Carpentier, Blondin, Virtanen, Richard, Haman and Turcotte. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Carpentier, André C.
Blondin, Denis P.
Virtanen, Kirsi A.
Richard, Denis
Haman, François
Turcotte, Éric E.
Brown Adipose Tissue Energy Metabolism in Humans
title Brown Adipose Tissue Energy Metabolism in Humans
title_full Brown Adipose Tissue Energy Metabolism in Humans
title_fullStr Brown Adipose Tissue Energy Metabolism in Humans
title_full_unstemmed Brown Adipose Tissue Energy Metabolism in Humans
title_short Brown Adipose Tissue Energy Metabolism in Humans
title_sort brown adipose tissue energy metabolism in humans
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090055/
https://www.ncbi.nlm.nih.gov/pubmed/30131768
http://dx.doi.org/10.3389/fendo.2018.00447
work_keys_str_mv AT carpentierandrec brownadiposetissueenergymetabolisminhumans
AT blondindenisp brownadiposetissueenergymetabolisminhumans
AT virtanenkirsia brownadiposetissueenergymetabolisminhumans
AT richarddenis brownadiposetissueenergymetabolisminhumans
AT hamanfrancois brownadiposetissueenergymetabolisminhumans
AT turcotteerice brownadiposetissueenergymetabolisminhumans